Pre-market · Oct 8, 8:20 am ET · After hours $16.06 -3.31%
Open$17.17
Prev close$17.29
Day range$16.12 – $17.67
Volume253.8K
Market cap$527.95M
P/E (TTM)–
Dividend yield–
BLSM Stock News
Headlines matching BlossomHill Therapeutics or the BLSM ticker, most recent first.
H.C. Wainwright Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $35Market news · 30 Sep 2026 · Direct mention
Analysts Offer Insights on NA Companies: Expedia (EXPE) and BlossomHill Therapeutics, Inc. (BLSM)TipRanks · 24 Sep 2026 · Direct mention
Analysts Conflicted on These NA Names: Guardian Metal Resources PLC Sponsored ADR (GMTL), BlossomHill Therapeutics, Inc. (BLSM) and International Paper Co (IP)TipRanks · 24 Sep 2026 · Direct mention
J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $30Market news · 24 Sep 2026 · Direct mention
Leerink Partners Initiates BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $40Market news · 22 Sep 2026 · Direct mention
Analysts Are Bullish on These NA Stocks: BlossomHill Therapeutics, Inc. (BLSM), Micron (MU)PositiveTipRanks · 21 Sep 2026 · Direct mention
A Quick Look at Today's Ratings for BlossomHill Therapeutics(BLSM.US), With a Forecast Between $28 to $35Market news · 2 Sep 2026 · Direct mention
J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy RatingMarket news · 18 Sep 2026 · Direct mention
Analysts Offer Insights on NA Companies: BlossomHill Therapeutics, Inc. (BLSM), Amrize Ltd (AMRZ) and ServiceTitan, Inc. Class A (TTAN)TipRanks · 18 Sep 2026 · Direct mention
LifeSci Capital Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $32Market news · 16 Sep 2026 · Direct mention
Discussion
No comments yet — be the first to weigh in on BLSM.
No comments yet — be the first to weigh in on BLSM.